miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2

Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C

(2020) Chao Yang et al.   Cancer Cell International

MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma

(2020) Laura Gramantieri et al.   CANCER RESEARCH

MicroRNA‐153‐3p regulates cell proliferation and cisplatin resistance via Nrf‐2 in esophageal squamous cell carcinoma

(2020) Jing Zuo et al.   Thoracic Cancer

The miR-28-5p Targetome Discovery Identified SREBF2 as One of the Mediators of the miR-28-5p Tumor Suppressor Activity in Prostate Cancer Cells

(2020) Sofia Fazio et al.   Cells

MicroRNA-197 inhibits the progression of osteosarcoma through targeting FOXM1

(2020) Chongxiao Sun et al.   Minerva Endocrinologica

Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma

(2018) Chunlei Cong et al.   Cancer Biomarkers

miR-149 as a Potential Molecular Target for Cancer

(2018) Suet H. Ow et al.   CURRENT MEDICINAL CHEMISTRY

MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2

(2018) Yuling Diao et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

miR-541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high-mobility group AT-hook 2

(2018) Li Xu et al.   Cancer Medicine

Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1

(2018) Bo Long et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MALAT1 promotes proliferation, migration, and invasion of MG63 cells by upregulation of TGIF2 via negatively regulating miR-129

(2018) Kai Liu et al.   OncoTargets and Therapy

Novel insights and therapeutic interventions for pediatric osteosarcoma

(2017) Leo Kager et al.   Future Oncology

Future directions in the treatment of osteosarcoma

(2016) Michael W. Bishop et al.   CURRENT OPINION IN PEDIATRICS

MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer

(2016) You-Jin Lu et al.   TUMOR BIOLOGY

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy

(2015) Chu Qin et al.   TUMOR BIOLOGY

High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth

(2013) Suvi-Katri Leivonen et al.   Molecular Oncology

Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage

(2008) S. D. Berman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA